T TAKEDA PHARMACEUTICAL CO LTD
| Market Cap | $59.20B |
| P/E Ratio | 85.18 |
| Forward P/E | 35.36 |
| Dividend Yield | 3.53% |
| Beta | 0.13 |
| 52W Range | $13.23 - $18.80 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Richard Pzena Pzena Investment Management | 0.00% | $321.00K | 20,627 | Buy |
Frequently Asked Questions
What is TAK stock price today?
TAKEDA PHARMACEUTICAL CO LTD (TAK) is currently trading at $18.74. The stock has a 52-week range of $13.23 to $18.80 and a market capitalization of $59.20B.
Is TAK a good stock to buy in 2026?
TAKEDA PHARMACEUTICAL CO LTD has a P/E ratio of 85.2 (forward P/E: 35.4), a dividend yield of 3.53%, and 1-year performance of +23.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling TAK stock?
There have been 0 insider transactions for TAK in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has TAK stock performed over the past year?
TAKEDA PHARMACEUTICAL CO LTD (TAK) has returned +23.4% over the past 12 months. The stock traded between $13.23 and $18.80 during this period, and is currently at $18.74.
Which hedge funds own TAK (TAKEDA PHARMACEUTICAL CO LTD)?
1 tracked hedge funds currently hold TAK in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is TAK's market cap and valuation?
TAKEDA PHARMACEUTICAL CO LTD (TAK) has a market capitalization of $59.20B. The trailing P/E ratio is 85.2 and forward P/E is 35.4. The stock is classified in the Healthcare sector.
What is TAK's revenue and profitability?
TAKEDA PHARMACEUTICAL CO LTD reported revenue of $4464.58B with net income of $112.93B and a profit margin of 0.03%. The stock has a beta of 0.13.
What sector is TAK in and who are its biggest institutional holders?
TAKEDA PHARMACEUTICAL CO LTD (TAK) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.